» Articles » PMID: 17337488

Accuracy of the 5-day FreeStyle Navigator Continuous Glucose Monitoring System: Comparison with Frequent Laboratory Reference Measurements

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2007 Mar 6
PMID 17337488
Citations 89
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The purpose of this study was to compare the accuracy of measurements of glucose in interstitial fluid made with the FreeStyle Navigator Continuous Glucose Monitoring System with Yellow Springs Instrument laboratory reference measurements of venous blood glucose.

Research Design And Methods: Fifty-eight subjects with type 1 diabetes, aged 18-64 years, were enrolled in a multicenter, prospective, single-arm study. Each subject wore two sensors simultaneously, which were calibrated with capillary fingerstick measurements at 10, 12, 24, and 72 h after insertion. Measurements from the FreeStyle Navigator system were collected at 1-min intervals and compared with venous measurements taken once every 15 min for 50 h over the 5-day period of sensor wear in an in-patient clinical research center. Periods of high rates of change of glucose were induced by insulin and glucose challenges.

Results: Comparison of the FreeStyle Navigator measurements with the laboratory reference method (n = 20,362) gave mean and median absolute relative differences (ARDs) of 12.8 and 9.3%, respectively. The percentage in the clinically accurate Clarke error grid A zone was 81.7% and that in the in the benign error B zone was 16.7%. During low rates of change (< +/-1 mg x dl(-1) x min(-1)), the percentage in the A zone was higher (84.9%) and the mean and median ARDs were lower (11.7 and 8.5%, respectively).

Conclusions: Measurements with the FreeStyle Navigator system were found to be consistent and accurate compared with venous measurements made using a laboratory reference method over 5 days of sensor wear (82.5% in the A zone on day 1 and 80.9% on day 5).

Citing Articles

Feasibility of a Glucose Manipulation Procedure for the Standardized Performance Evaluation of Continuous Glucose Monitoring Systems.

Link M, Eichenlaub M, Waldenmaier D, Wehrstedt S, Pleus S, Jendrike N J Diabetes Sci Technol. 2025; :19322968251317526.

PMID: 39989334 PMC: 11848859. DOI: 10.1177/19322968251317526.


Accuracy of a continuous glucose monitoring system applied before, during, and after an intense leg-squat session with low- and high-carbohydrate availability in young adults without diabetes.

Matzka M, Ortenblad N, Lenk M, Sperlich B Eur J Appl Physiol. 2024; 124(12):3557-3569.

PMID: 39037631 PMC: 11569006. DOI: 10.1007/s00421-024-05557-5.


Coin-sized, fully integrated, and minimally invasive continuous glucose monitoring system based on organic electrochemical transistors.

Bai J, Liu D, Tian X, Wang Y, Cui B, Yang Y Sci Adv. 2024; 10(16):eadl1856.

PMID: 38640241 PMC: 11029813. DOI: 10.1126/sciadv.adl1856.


A Critical Discussion of Alert Evaluations in the Context of Continuous Glucose Monitoring System Performance.

Pleus S, Eichenlaub M, Waldenmaier D, Freckmann G J Diabetes Sci Technol. 2024; 18(4):847-856.

PMID: 38477308 PMC: 11307228. DOI: 10.1177/19322968241236504.


Current Technologies for Managing Type 1 Diabetes Mellitus and Their Impact on Quality of Life-A Narrative Review.

Elian V, Popovici V, Ozon E, Musuc A, Fita A, Rusu E Life (Basel). 2023; 13(8).

PMID: 37629520 PMC: 10456000. DOI: 10.3390/life13081663.